Physician profile
Dora Eda Achille
NPI 1013952514
$1,641.23
in general payments reported to CMS, 2019-2025
22 companies · $43.85 in 2025
The $43.85 reported for 2025 was less than what a typical Primary Podiatric Medicine provider received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $434 · 2020: $636 · 2021: $279 · 2022: $144 · 2023: $76.66 · 2024: $28.46 · 2025: $43.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $148.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medimetriks Pharmaceuticals, INC. | $357.89 | 2020 | |
| Smith+Nephew, INC. | $300.22 | 2019-2021 | |
| Zyla Life Sciences, INC. | $281.49 | 2019-2020 | |
| Melinta Therapeutics, LLC | $164.08 | 2019-2022 | |
| Nabriva Therapeutics, Plc | $57.36 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $53.88 | 2021-2024 | Nuzyra |
| Ibsa Pharma INC. | $50.17 | 2021-2023 | Tirosint, Licart |
| Abbott Laboratories | $49.58 | 2021-2022 | |
| Horizon Therapeutics Plc | $41.42 | 2020-2022 | |
| Orthofix Medical, INC. | $40.12 | 2019-2024 | Physio-Stim |
| Tactile Systems Technology INC | $34.44 | 2019-2020 | |
| Arteriocyte Medical Systems, INC. | $33.65 | 2019 | |
| Averitas Pharma INC. | $27.84 | 2025 | Qutenza |
| Bioventus LLC | $25.33 | 2020-2021 | |
| Nevro Corp. | $19.97 | 2023 | Senza |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $19.48 | 2021 | |
| Treace Medical Concepts, INC. | $16.01 | 2025 | |
| Advanced Oxygen Therapy INC. | $15.01 | 2022 | |
| Sebela Pharmaceuticals INC. | $14.45 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $13.79 | 2023 | Jublia |
| Medtronic, INC. | $13.23 | 2022 | |
| Merck Sharp & Dohme LLC | $11.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dora Achille listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.